Stereotaxis (STXS) Cash from Operations (2010 - 2026)
Stereotaxis' (STXS) quarterly Cash from Operations came in at -$3.4 million in Q1 2026, down 93.48% year-over-year from -$52.8 million in Q1 2025, and up 13.28% quarter-over-quarter from -$4.0 million in Q4 2025.
Analysis
Stereotaxis (STXS) Cash from Operations (2010 - 2026) Analysis & Trends
Stereotaxis (STXS) has reported Cash from Operations for 17 consecutive years, with -$3.4 million the latest figure, recorded in Q1 2026.
- On a quarterly basis, Cash from Operations fell 93.48% year-over-year to -$3.4 million in Q1 2026; TTM through Mar 2026 was -$15.3 million, a 93.54% decrease from a year earlier, with the FY2025 full-year figure at -$13.7 million, down 61.06% from the prior year.
- Cash from Operations was -$3.4 million for Q1 2026 at Stereotaxis, up from -$4.0 million in the prior quarter.
- Over five years, Cash from Operations peaked at $1.3 million in Q4 2024 and troughed at -$4.3 million in Q3 2024.
- A 5-year average of -$2.5 million and a median of -$2.6 million in 2022 frame the typical range for Cash from Operations.
- Across the five-year window, Cash from Operations sank 3444.12% in 2022 and jumped 151.91% in 2024, its largest moves.
- Over 5 years, Cash from Operations stood at -$2.6 million in 2022, then increased by 4.43% to -$2.4 million in 2023, then jumped by 151.91% to $1.3 million in 2024, then plunged by 413.51% to -$4.0 million in 2025, then grew by 13.28% to -$3.4 million in 2026.
- The last three Cash from Operations figures came in at -$3.4 million (Q1 2026), -$4.0 million (Q4 2025), and -$4.2 million (Q3 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 179.79 Bn | 174.18 Bn | 7.27 Bn | 2.49 Bn |
| 2 | Intuitive Surgical | 127.69 Bn | 122.47 Bn | 1.96 Bn | 1.06 Bn |
| 3 | Medtronic | 117.23 Bn | 108.41 Bn | 6.34 Bn | 1.79 Bn |
| 4 | Stryker | 103.55 Bn | 100.07 Bn | 4.50 Bn | 1.26 Bn |
| 5 | Boston Scientific | 63.24 Bn | 62.70 Bn | 3.85 Bn | 1.47 Bn |
| 6 | Edwards Lifesciences | 49.97 Bn | 45.72 Bn | 1.35 Bn | 651.90 Mn |
| 7 | Alcon | 32.83 Bn | 31.37 Bn | 1.68 Bn | 510.00 Mn |
| 8 | Dexcom | 32.30 Bn | 30.35 Bn | 830.00 Mn | 269.20 Mn |
| 9 | Steris | 20.73 Bn | 20.25 Bn | 684.20 Mn | 367.10 Mn |
| 10 | Stereotaxis | 129.55 Mn | 114.93 Mn | 3.79 Mn | -3.44 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | -3.44 Mn |
| Dec 31, 2025 | -3.97 Mn |
| Sep 30, 2025 | -4.20 Mn |
| Jun 30, 2025 | -3.73 Mn |
| Mar 31, 2025 | -1.78 Mn |
| Dec 31, 2024 | 1.27 Mn |
| Sep 30, 2024 | -4.33 Mn |
| Jun 30, 2024 | -3.09 Mn |
| Mar 31, 2024 | -2.35 Mn |
| Dec 31, 2023 | -2.44 Mn |
| Sep 30, 2023 | -967,000.00 |
| Jun 30, 2023 | -2.93 Mn |
| Mar 31, 2023 | -2.80 Mn |
| Dec 31, 2022 | -2.55 Mn |
| Sep 30, 2022 | -2.53 Mn |
| Jun 30, 2022 | -1.14 Mn |
| Mar 31, 2022 | -2.19 Mn |
| Dec 31, 2021 | -1.22 Mn |
| Sep 30, 2021 | -1.46 Mn |
| Jun 30, 2021 | 34,000.00 |